Publications by authors named "Keith Shilkin"

Claim this Profile
T
The Wittenoom legacy.
Arthur W Bill Musk, Alison Reid, Nola Olsen, Michael Hobbs, Bruce Armstrong, Keith Shilkin

Int J Epidemiol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma.
Sanjeevan Muruganandan, Helman Alfonso, Peter Franklin, Keith Shilkin, Amanda Segal

Br J Cancer· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit.
Amanda Segal, Gregory F Sterrett, Felicity A Frost, Keith B Shilkin, Nola J Olsen

Pathology· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation.
Nola J Olsen, Peter J Franklin, Alison Reid, Nicholas H de Klerk, Timothy J Threlfall, Keith Shilkin

Med J Aust· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of reproductive toxicity of piperaquine in mice.
Kevin T Batty, Brioni R Moore, Verity Stirling, Kenneth F Ilett, Madhu Page-Sharp, Keith B Shilkin

Reprod Toxicol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicology and pharmacokinetics of piperaquine in mice.
Kevin T Batty, Brioni R Moore, Verity Stirling, Kenneth F Ilett, Madhu Page-Sharp, Keith B Shilkin

Toxicology· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The diagnosis and attribution of asbestos-related diseases in an Australian context: report of the Adelaide Workshop on Asbestos-Related Diseases. October 6-7, 2000.
Douglas W Henderson, Michael L Jones, Nicholas De Klerk, James Leigh, A William Musk, Keith B Shilkin

Int J Occup Environ Health· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
Vito J Spataro, Heather Litman, Giuseppe Viale, Fausto Maffini, Michele Masullo, Keith B Shilkin

Cancer· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis